CC BY 4.0 · Indian J Med Paediatr Oncol
DOI: 10.1055/s-0045-1802636
Case Report with Review of Literature

An Uncommon Case Report of Malignant Epithelial Ovarian Neoplasm in the Pediatric Age Group with a Brief Literature Review

Pratiksha Mishra
1   Department of Pathology, Srirama Chandra Bhanja Medical College and Hospital, Cuttack, Orissa, India
,
Subhransu Kumar Hota
1   Department of Pathology, Srirama Chandra Bhanja Medical College and Hospital, Cuttack, Orissa, India
,
Sagarika Samantaray
2   Department of Oncopathology, Acharya Harihar Post Graduate Institute of Cancer, Cuttack, Orissa, India
,
Rabi Narayan Mallick
3   Patholab Healthcare Pvt. Ltd, Cuttack, Orissa, India
,
Padmalaya Nayak
3   Patholab Healthcare Pvt. Ltd, Cuttack, Orissa, India
› Author Affiliations
Funding None.

Abstract

Epithelial ovarian neoplasm is the most common gynecological malignancy causing mortality in adults, but is a rare diagnosis in children and adolescents. The majority of the malignancies found in adolescents are of germ cell origin. Low-grade serous ovarian malignancies may arise de novo or may follow already diagnosed case of serous borderline tumor. Clinically, patients present with nonspecific symptoms like lower abdominal pain. Apart from radiology, it is equally important to carry out histopathology, which shows numerous micropapillary structures having scant fibrovascular cores. We report a rare case of low-grade papillary serous ovarian neoplasm in a 5-year-old girl, wherein we discuss the need to do thorough clinical, radiological, pathological, and biochemical investigations for all women despite age category so as to provide adequate management on time.

Patient Consent

Informed consent was taken from the patient party.


Authors' Contributions

P.M. made significant contributions to literature search, data acquisition, and manuscript preparation. S.K.H. made significant contributions to concepts, design, definition of intellectual content, and manuscript review, and is a guarantor. S.S. made significant contributions to concepts, design, definition of intellectual content, and manuscript review. R.N.M. has made contribution to intellectual content and manuscript review. P.N. made significant contributions to manuscript review and concepts.




Publication History

Article published online:
03 March 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
  • 2 Oluwasola TA, Abdus-Salam RA, Okolo CA, Odukogbe AT. Bilateral ovarian serous cystadenocarcinoma in a teenager: a case report. Pan Afr Med J 2017; 28 (01) 18
  • 3 Rickards J, Brooks BA, Rivera-Betancourt A, Velasquez D. A rare case of low-grade serous cystadenocarcinoma of the ovary in a seventeen-year-old woman. Cureus 2022; 14 (08) e28086
  • 4 Matsuo K, Machida H, Grubbs BH, Sood AK, Gershenson DM. Trends of low-grade serous ovarian carcinoma in the United States. J Gynecol Oncol 2018; 29 (01) e15
  • 5 Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004; 164 (05) 1511-1518
  • 6 Malpica A, Deavers MT, Lu K. et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 2004; 28 (04) 496-504
  • 7 Okoye E, Euscher ED, Malpica A. Ovarian low-grade serous carcinoma: a clinicopathologic study of 33 cases with primary surgery performed at a single institution. Am J Surg Pathol 2016; 40 (05) 627-635
  • 8 Nguyen L, Cardenas-Goicoechea SJ, Gordon P. et al. Biomarkers for early detection of ovarian cancer. Womens Health (Lond) 2013; 9 (02) 171-185
  • 9 Singer G, Oldt 3rd R, Cohen Y. et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003 Mar 19; 95 (06) 484-6
  • 10 Moen MD, Cliby WA, Wilson TO. Stage III papillary serous cystadenocarcinoma of the ovary in a 15-year-old female. Gynecol Oncol 1994; 53 (02) 274-276
  • 11 Zhou S, Guo Y, Wen L. et al. Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors' subjective judgment. BMC Med Imaging 2023; 23 (01) 190
  • 12 Alcid J, Shahin MS. Low-grade serous carcinoma of the ovary: a case series and literature review. J Case Rep Images Oncology 2018; 4: 100052Z10JA2018
  • 13 Nasioudis D, Alevizakos M, Holcomb K, Witkin SS. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population. Maturitas 2017; 96: 45-50
  • 14 Gupta R, Bal A, Das A, Kumar Marwah R. Serous cystadenocarcinoma of the ovary in an 11-year-old girl with extensive dissemination and chylothorax: a case report and a brief review of literature. J Pediatr Hematol Oncol 2009; 31 (07) 533-535
  • 15 Raney Jr RB, Sinclair L, Uri A, Schnaufer L, Cooper A, Littman P. Malignant ovarian tumors in children and adolescents. Cancer 1987; 59 (06) 1214-1220
  • 16 Babaier A, Mal H, Alselwi W, Ghatage P. Low-grade serous carcinoma of the ovary: the current status. Diagnostics (Basel) 2022; 12 (02) 458
  • 17 Schmeler KM, Pareja R, Lopez Blanco A. et al. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer 2021; 31 (10) 1317-1325